First crystal structures of pharmaceutical ibrutinib: systematic solvate screening and characterization

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68378271%3A_____%2F17%3A00479592" target="_blank" >RIV/68378271:_____/17:00479592 - isvavai.cz</a>
Alternative codes found
RIV/60461373:22340/17:43914801
Result on the web
<a href="http://dx.doi.org/10.1021/acs.cgd.7b00047" target="_blank" >http://dx.doi.org/10.1021/acs.cgd.7b00047</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1021/acs.cgd.7b00047" target="_blank" >10.1021/acs.cgd.7b00047</a>

Result language
angličtina
Original language name
First crystal structures of pharmaceutical ibrutinib: systematic solvate screening and characterization
Original language description
A search for new solid forms of an active pharmaceutical ingredient (API) is an integral part of the drug product development process. The studied compound, Ibrutinib, is a recently approved anticancer drug. The main aim of this study was to search for new solvates of Ibrutinib and to perform their structural characterization.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10302 - Condensed matter physics (including formerly solid state physics, supercond.)

Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)